Vivace Therapeutics is an oncology-focused small molecule drug discovery and development company.
Location: United States, California, Princeton-by-the-Sea
Employees: 11-50
Total raised: $70M
Founded date: 2014
Investors 4
| Date | Name | Website |
| - | Mission Bi... | missionbio... |
| - | 6 Dimensio... | 6dimension... |
| - | RA Capital... | racap.com |
| - | Canaan Par... | canaan.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 17.12.2020 | Series C | $30M | - |
| 28.06.2017 | Series A | $40M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 16.04.2023 | Researchers Report Clinical Proof-of-Concept Data for Vivace... | First-in-Class TEAD Autopalmitoylation Inhibitor is Well Tolerated and Demonstrates Antitumor Activi... | einpresswi... |
| 17.12.2020 | Endpoints News: Vivace Therapeutics scores $30M Series C to ... | - | canaan.com... |
| 17.12.2020 | Vivace Therapeutics Raises $30M in Series C Financing | Vivace Therapeutics, Inc., a San Mateo, CA-based small molecule discovery and development company de... | finsmes.co... |
| 16.12.2020 | Vivace Therapeutics Announces $30 Million Series C Financing... | SAN MATEO, Calif., Dec. 16, 2020 /PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discove... | marketscre... |
| 28.06.2017 | Vivace Therapeutics Raises $40M in Series A and Series B Fun... | Vivace Therapeutics, a San Mateo, Calif.-based oncology-focused portfolio-based drug discovery and d... | finsmes.co... |